Healthcare provider profile · identity verified

David Bryan Cox, M.D.

Family Practice · EASTPOINTE, MI · NPI 1740554666

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	171
Amlodipine Besylate	Amlodipine Besylate	500	140
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	396	73
Losartan Potassium	Losartan Potassium	360	108
Lisinopril	Lisinopril	297	92
Metformin Hcl	Metformin Hcl	211	70
Omeprazole	Omeprazole	211	73
Tamsulosin Hcl	Tamsulosin Hcl	205	66
Gabapentin	Gabapentin	201	55
Levothyroxine Sodium	Levothyroxine Sodium	193	56
Testosterone Cypionate	Testosterone Cypionate	188	19
Alprazolam	Alprazolam	180	26
Rosuvastatin Calcium	Rosuvastatin Calcium	176	58
Metoprolol Succinate	Metoprolol Succinate	166	48
Albuterol Sulfate Hfa	Albuterol Sulfate	148	35
Simvastatin	Simvastatin	145	39
Hydrochlorothiazide	Hydrochlorothiazide	130	36
Metoprolol Tartrate	Metoprolol Tartrate	112	41
Furosemide	Furosemide	106	35
Ozempic	Semaglutide	91	24
Chlorthalidone	Chlorthalidone	88	28
Eliquis	Apixaban	88	29
Fluticasone Propionate	Fluticasone Propionate	88	40
Atenolol	Atenolol	87	25
Jardiance	Empagliflozin	84	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	30
Potassium Chloride	Potassium Chloride	81	21
Carvedilol	Carvedilol	80	28
Metformin Hcl Er	Metformin Hcl	79	26
Ventolin Hfa	Albuterol Sulfate	72	23
Escitalopram Oxalate	Escitalopram Oxalate	70	19
Clonazepam	Clonazepam	68	14
Allopurinol	Allopurinol	67	23
Pravastatin Sodium	Pravastatin Sodium	65	18
Lorazepam	Lorazepam	63	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	16
Pantoprazole Sodium	Pantoprazole Sodium	59	19
Hydralazine Hcl	Hydralazine Hcl	55	18
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	53	53
Tramadol Hcl	Tramadol Hcl	53	14
Trazodone Hcl	Trazodone Hcl	51	18
Duloxetine Hcl	Duloxetine Hcl	50	15
Mirtazapine	Mirtazapine	49	14
Finasteride	Finasteride	47	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	13
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Nifedipine Er	Nifedipine	45	17
Prednisone	Prednisone	45	21
Trulicity	Dulaglutide	45	11
Ezetimibe	Ezetimibe	44	14
Pregabalin	Pregabalin	44	12
Benazepril Hcl	Benazepril Hcl	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	40	11
Meloxicam	Meloxicam	40	suppressed
Baclofen	Baclofen	38	11
Pioglitazone Hcl	Pioglitazone Hcl	38	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	11
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	14
Famotidine	Famotidine	33	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	16
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	28
Ibuprofen	Ibuprofen	32	13
Sertraline Hcl	Sertraline Hcl	31	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	31	27
Alendronate Sodium	Alendronate Sodium	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Spironolactone	Spironolactone	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Temazepam	Temazepam	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Lactulose	Lactulose	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Tiotropium Bromide	Tiotropium Bromide	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	11
Loperamide	Loperamide Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Eplerenone	Eplerenone	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error